Fractalkine/CX3CR1 Contributes to Endometriosis-Induced Neuropathic Pain and Mechanical Hypersensitivity in Rats

Fractalkine/CX3CR1 Contributes to Endometriosis-Induced Neuropathic Pain and Mechanical Hypersensitivity in Rats

Pain is the most severe and common symptom of endometriosis. Its underlying pathogenetic mechanism is poorly understood. Nerve sensitization is a particular research challenge, due to the limitations of general endometriosis models and sampling nerve tissue from patients. The chemokine fractalkine (...

Full description

Bibliographic Details
Main Authors:	Zhiming Liu, Sisi Chen, Chunping Qiu, Yaqiong Sun, Wenzhi Li, Jie Jiang, Jun-Ming Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-12-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	endometriosis fractalkine neuropathic pain inflammation microglia peripheral hyperalgesia
Online Access:	https://www.frontiersin.org/article/10.3389/fncel.2018.00495/full

Similar Items

Fractalkine/CX3CR1 Pathway in Neuropathic Pain: An Update
by: Rita Silva, et al.
Published: (2021-07-01)

The Role of C Fibers in Spinal Microglia Induction and Possible Relation with TRPV3 Expression During Chronic Inflammatory Arthritis in Rats
by: Sasan Gazerani, et al.
Published: (2016-07-01)

Fractalkine/CX3CR1 pathway is neuroprotective in intracerebral hemorrhage through facilitating the expression of TGF-β1
by: Hai-Han Yu, et al.
Published: (2020-09-01)

Glabridin Therapy Reduces Chronic Allodynia, Spinal Microgliosis, and Dendritic Spine Generation by Inhibiting Fractalkine-CX3CR1 Signaling in a Mouse Model of Tibial Fractures
by: Juan Long, et al.
Published: (2023-04-01)

CX<sub>3</sub>CL1 (fractalkine) and CX<sub>3</sub>CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin
by: Olsson Tomas, et al.
Published: (2005-07-01)

Neuron–glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage
by: Graham K. Sheridan, et al.
Published: (2013-01-01)

Fractalkine/CX3CR1 signalling during neuropathic pain
by: Anna K Clark, et al.
Published: (2014-05-01)

Examination of the Fractalkine and Fractalkine Receptor Expression in Fallopian Adenocarcinoma Reveals Differences When Compared to Ovarian Carcinoma
by: Hilal Gurler, et al.
Published: (2015-12-01)

Implications of fractalkine on glial function, ablation and glial proteins/receptors/markers—understanding its therapeutic usefulness in neurological settings: a narrative review
by: Deepraj Paul, et al.
Published: (2022-12-01)

The core of maintaining neuropathic pain: Crosstalk between glial cells and neurons (neural cell crosstalk at spinal cord)
by: Tianrui Zhang, et al.
Published: (2023-02-01)

Fractalkine isoforms differentially regulate microglia-mediated inflammation and enhance visual function in the diabetic retina
by: Derek Rodriguez, et al.
Published: (2024-02-01)

Therapeutic Delivery of Soluble Fractalkine Ameliorates Vascular Dysfunction in the Diabetic Retina
by: Derek Rodriguez, et al.
Published: (2024-01-01)

Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
by: Liao Jun, et al.
Published: (2023-12-01)

Reduced brain fractalkine-CX3CR1 signaling is involved in the impaired cognition of streptozotocin-treated mice
by: Namiko Kawamura, et al.
Published: (2020-12-01)

Fractalkine/CX<sub>3</sub>CR1 in Dilated Cardiomyopathy: A Potential Future Target for Immunomodulatory Therapy?
by: Visvesh Jeyalan, et al.
Published: (2023-09-01)

Fractalkine/CX3CL1 in Neoplastic Processes
by: Jan Korbecki, et al.
Published: (2020-05-01)

Role of the Fractalkine Receptor in CNS Autoimmune Inflammation: New Approach Utilizing a Mouse Model Expressing the Human CX3CR1I249/M280 Variant
by: Sandra M. Cardona, et al.
Published: (2018-10-01)

Triptolide alleviates cerebral ischemia/reperfusion injury via regulating the Fractalkine/CX3CR1 signaling pathway
by: Jiajun Zhou, et al.
Published: (2024-06-01)

Defective microglial development in the hippocampus of Cx3cr1 deficient mice
by: Francesca ePagani, et al.
Published: (2015-03-01)

Role of fractalkine–CX3CR1 pathway in seizure-induced microglial activation, neurodegeneration, and neuroblast production in the adult rat brain
by: Idrish Ali, et al.
Published: (2015-02-01)

Voluntary Wheel Running Reduces Vesicle Development in an Endometriosis Animal Model Through Modulation of Immune Parameters
by: Caroline B. Appleyard, et al.
Published: (2022-01-01)

Camphor Attenuates Hyperalgesia in Neuropathic Pain Models in Mice
by: Li Z, et al.
Published: (2023-03-01)

Fractalkine Signalling (CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 Axis) as an Emerging Target in Coronary Artery Disease
by: Shu Xian Loh, et al.
Published: (2023-07-01)

CLINICAL AND DIAGNOSTIC VALUE OF THE DETERMINANTION OF FRACTALKINE IN ATOPIC DERMATITIS OF CHILDREN
by: M M Ben, et al.
Published: (2018-12-01)

Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
by: Sarah Cormican, et al.
Published: (2021-06-01)

Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice
by: Aimee N. Winter, et al.
Published: (2020-05-01)

Effect of ethosucximide on the reduction of neuropathic pain due to chronic constriction of the sciatic nerve in rats
by: Gholam Ali Hamidi, et al.
Published: (2013-05-01)

Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation
by: Hariharakrishnan Chidambaram, et al.
Published: (2020-09-01)

Pathological Role of Fractalkine/CX3CL1 in Rheumatic Diseases: A unique chemokine with multiple functions
by: Brian A. Jones, et al.
Published: (2012-01-01)

The antinociceptive effect of acetaminophen in a rat model of neuropathic pain
by: Kyong-Shil Im, et al.
Published: (2012-05-01)

Gabapentin enhances anti-nociceptive effects of morphine on heat, cold, and mechanical hyperalgesia in a rat model of neuropathic pain
by: Gholam Ali Hamidi, et al.
Published: (2014-10-01)

CX3CL1 Action on Microglia Protects from Diet-Induced Obesity by Restoring POMC Neuronal Excitability and Melanocortin System Activity Impaired by High-Fat Diet Feeding
by: Jineta Banerjee, et al.
Published: (2022-06-01)

The chemokine fractalkine (CX3CL1) attenuates H2O2-induced demyelination in cerebellar slices
by: Sinead A. O’Sullivan, et al.
Published: (2017-08-01)

Leptin and fractalkine: novel subcutaneous cytokines in burn injury
by: Dominic Friston, et al.
Published: (2020-04-01)

Effect of biotin supplementation on neuropathic pain induced by chronic constriction of the sciatic nerve in the rat
by: Ali-Reza Abed, et al.
Published: (2021-01-01)

Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications
by: Harshavardhan Lingegowda, et al.
Published: (2022-10-01)

Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients
by: Valentina Marchica, et al.
Published: (2019-03-01)

Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases
by: Tanaka Y, et al.
Published: (2020-11-01)

FRACTALKINE: PATHOGENIC ROLE AND DIAGNOSTIC CAPABILITIES
by: O. A. MESNYANKINA, et al.
Published: (2017-06-01)

Serum Levels and in vitro CX3CL1 (Fractalkine), CXCL8, and IL-10 Synthesis in Phytohemaglutinin-Stimulated and Non-stimulated Peripheral Blood Mononuclear Cells in Subjects With Schizophrenia
by: Jaśmina Arabska, et al.
Published: (2022-06-01)